LIB Therapeutics & Hasten Biopharmaceuticals’ Lerodalcibep Trial Approved in China
LIB Therapeutics, Inc. (LIB), a pioneering biopharmaceutical company, has made considerable progress with its cholesterol-lowering drug, Lerodalcibep and designed...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage CRO Consolidation Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials protocol amendments Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
LIB Therapeutics, Inc. (LIB), a pioneering biopharmaceutical company, has made considerable progress with its cholesterol-lowering drug, Lerodalcibep and designed...
The “Global Digital Biomarkers Market – Outlook & Forecast 2024-2029” report showcases the rapidly expanding digital biomarkers market, which...
eGenesis, a pioneering biotechnology company, has announced a groundbreaking advancement in transplantation with the successful transplantation of a genetically...
The continent of Africa stands at a fascinating juncture in clinical trials, presenting a blend of untapped potential and...
Bristol Myers Squibb (BMY) has revealed positive outcomes from the Phase 3 CheckMate -9DW clinical trial, showcasing the effectiveness...
Tevogen Bio Holdings announced the enduring efficacy of its investigational COVID-19 treatment, TVGN 489, against the latest dominant SARS-CoV-2...
CND Life SciencesLife Sciences, a leading medical technology company specializing in neurodiagnostic tests, has announced a groundbreaking publication in...
AstraZeneca has announced a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focusing on developing next-generation...
Cybin Inc., a clinical-stage biopharmaceutical company focused on creating innovative psychedelic-based treatments for mental health disorders, recently completed a...
AIC, a division of AIS Healthcare, has enriched its portfolio of infusion therapies by offering GLASSIA and ARALAST NP,...